This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EARLY-BIRD PRICING ENDS IN:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Hans van der Vliet, PhD, MD
Chief Scientific Officer at Lava Therapeutics BV

Profile

Hans van der Vliet, MD PhD is a medical oncologist and associate professor at the department of medical oncology of the Amsterdam UMC, VU University and Cancer Center Amsterdam and scientific founder and CSO of Lava Therapeutics B.V., a biotech company that develops proprietary Vγ9Vδ2 T-cell engagers.

Agenda Sessions

  • Bispecific T cell Engagers

    9:45am
  • Bispecific γδ-T cell Engagers for Cancer Immunotherapy

    On Demand